10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 273 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $517,701 | -43.3% | 26,617 | +9.4% | 0.00% | -50.0% |
| Q1 2024 | $913,105 | -33.6% | 24,330 | -0.9% | 0.01% | -40.0% |
| Q4 2023 | $1,374,490 | +40.3% | 24,562 | +3.4% | 0.01% | +25.0% |
| Q3 2023 | $979,646 | -28.6% | 23,749 | -3.3% | 0.01% | -27.3% |
| Q2 2023 | $1,371,207 | +10.9% | 24,556 | +10.8% | 0.01% | 0.0% |
| Q1 2023 | $1,236,251 | +58.1% | 22,159 | +3.3% | 0.01% | +37.5% |
| Q4 2022 | $781,857 | +19.6% | 21,456 | -6.6% | 0.01% | +14.3% |
| Q3 2022 | $654,000 | -36.5% | 22,972 | +0.9% | 0.01% | -30.0% |
| Q2 2022 | $1,030,000 | -37.5% | 22,756 | +5.0% | 0.01% | -23.1% |
| Q1 2022 | $1,648,000 | -47.2% | 21,670 | +3.3% | 0.01% | -45.8% |
| Q4 2021 | $3,124,000 | +3.1% | 20,969 | +0.7% | 0.02% | -4.0% |
| Q3 2021 | $3,031,000 | -25.1% | 20,817 | +0.7% | 0.02% | -24.2% |
| Q2 2021 | $4,049,000 | +21.0% | 20,679 | +11.8% | 0.03% | +13.8% |
| Q1 2021 | $3,347,000 | +34.3% | 18,489 | +5.0% | 0.03% | +26.1% |
| Q4 2020 | $2,493,000 | – | 17,605 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |